Key Protein MNDA May Drive Immune System Aging and Age-Related Disease Risk

This research reveals how a protein called MNDA (Myeloid cell Nuclear Differentiation Antigen) may be a key driver of immune system aging, offering new insights into why our immunity declines with age and disease risk increases.

The study examined how MNDA regulates the balance between different immune cell types. During healthy aging, the immune system undergoes 'myeloid bias' - producing more inflammatory myeloid cells while reducing protective lymphoid cells. MNDA, activated by interferon signals, controls this process by regulating gene expression and promoting cell death in specific immune cells.

Researchers found MNDA is particularly enriched in M2 macrophages and myeloid-derived suppressor cells (MDSCs). While these cells can resolve inflammation, they may also promote cellular senescence and tissue damage when overactive. The protein works by partnering with transcription factors and inhibiting anti-death proteins, helping clear immune cells during inflammation resolution.

The scientists propose a concerning cycle: aging leads to DNA leakage from damaged mitochondria and cell nuclei, which activates DNA sensors and interferon pathways. This increases MNDA production, further skewing immune cell development toward the inflammatory myeloid lineage. This self-reinforcing process may accelerate immune aging and worsen age-related diseases.

For longevity, this research suggests that interventions targeting the interferon-MNDA pathway could help maintain balanced immune function during aging. Strategies might include supporting mitochondrial health to prevent DNA leakage, or developing therapies that modulate MNDA activity. However, since MNDA also helps resolve inflammation, any interventions would need careful calibration to preserve beneficial immune responses while preventing excessive myeloid bias.